Gentian Diagnostics Past Earnings Performance
Past criteria checks 0/6
Gentian Diagnostics has been growing earnings at an average annual rate of 22.1%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 21.8% per year.
Key information
22.1%
Earnings growth rate
21.3%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | 21.8% |
| Return on equity | -3.9% |
| Net Margin | -3.9% |
| Next Earnings Update | 29 Aug 2024 |
Recent past performance updates
Recent updates
Analyst Estimates: Here's What Brokers Think Of Gentian Diagnostics ASA (OB:GENT) After Its Annual Report
Feb 14
Here's Why We're Not At All Concerned With Gentian Diagnostics' (OB:GENT) Cash Burn Situation
Oct 28We're Not Worried About Gentian Diagnostics' (OB:GENT) Cash Burn
May 11Can You Imagine How Gentian Diagnostics' (OB:GENT) Shareholders Feel About The 57% Share Price Increase?
Mar 20What Percentage Of Gentian Diagnostics AS (OB:GENT) Shares Do Insiders Own?
Feb 21Have Insiders Been Selling Gentian Diagnostics AS (OB:GENT) Shares?
Jan 17
Gentian Diagnostics AS (OB:GENT): When Will It Breakeven?
Dec 14Revenue & Expenses BreakdownBeta
How Gentian Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 149 | -6 | 41 | -2 |
| 31 Dec 23 | 142 | -11 | 41 | 0 |
| 30 Sep 23 | 135 | -5 | 41 | 0 |
| 30 Jun 23 | 126 | -14 | 39 | 0 |
| 31 Mar 23 | 122 | -18 | 41 | 0 |
| 31 Dec 22 | 112 | -24 | 37 | 0 |
| 30 Sep 22 | 106 | -29 | 37 | 0 |
| 30 Jun 22 | 100 | -26 | 35 | 0 |
| 31 Mar 22 | 99 | -26 | 34 | 0 |
| 31 Dec 21 | 100 | -25 | 34 | 0 |
| 30 Sep 21 | 99 | -19 | 31 | 0 |
| 30 Jun 21 | 96 | -19 | 31 | 0 |
| 31 Mar 21 | 84 | -17 | 30 | -6 |
| 31 Dec 20 | 79 | -17 | 31 | 0 |
| 30 Sep 20 | 72 | -21 | 28 | -15 |
| 30 Jun 20 | 70 | -19 | 28 | -9 |
| 31 Mar 20 | 62 | -38 | 27 | 2 |
| 31 Dec 19 | 55 | -40 | 26 | 0 |
| 30 Sep 19 | 44 | -46 | 25 | 1 |
| 30 Jun 19 | 48 | -41 | 25 | 1 |
| 31 Mar 19 | 47 | -23 | 23 | 1 |
| 31 Dec 18 | 46 | -20 | 20 | 0 |
| 30 Sep 18 | 51 | -12 | 6 | 14 |
| 30 Jun 18 | 41 | -16 | 10 | 9 |
| 31 Mar 18 | 40 | -14 | 15 | 3 |
| 31 Dec 17 | 35 | -15 | 22 | 0 |
| 30 Sep 17 | 34 | -13 | 28 | 0 |
| 30 Jun 17 | 32 | -12 | 26 | 0 |
| 31 Mar 17 | 30 | -13 | 22 | 0 |
| 31 Dec 16 | 31 | -9 | 17 | 0 |
| 31 Dec 15 | 26 | -3 | 13 | 0 |
| 31 Dec 14 | 25 | -3 | 10 | 0 |
| 31 Dec 13 | 23 | 1 | 9 | 0 |
Quality Earnings: GENT is currently unprofitable.
Growing Profit Margin: GENT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GENT is unprofitable, but has reduced losses over the past 5 years at a rate of 22.1% per year.
Accelerating Growth: Unable to compare GENT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GENT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.8%).
Return on Equity
High ROE: GENT has a negative Return on Equity (-3.85%), as it is currently unprofitable.